PureTech Health (PRTC)
PureTech Health Statistics
Share Statistics
PureTech Health has 24.02M shares outstanding. The number of shares has increased by 8.48% in one year.
| 24.02M |
| 8.48% |
| 0.32% |
| 0.14% |
| n/a |
| 3 |
| 0.06% |
Short Selling Information
The latest short interest is 8.13K, so 0.03% of the outstanding shares have been sold short.
| 8.13K |
| 0.03% |
| 0.05% |
| 4.95 |
Valuation Ratios
The PE ratio is 9.3 and the forward PE ratio is -3.44. PureTech Health's PEG ratio is -0.09.
| 9.3 |
| -3.44 |
| 115.36 |
| 1 |
| 1.2 |
| -3.7 |
| -0.09 |
Enterprise Valuation
PureTech Health has an Enterprise Value (EV) of 4.72B.
| 1093.77 |
| 126.25 |
| -35.12 |
| -35.12 |
Financial Position
The company has a current ratio of 9.33, with a Debt / Equity ratio of 0.05.
| 9.33 |
| 9.33 |
| 0.05 |
| 0.6 |
| -0.17 |
| -13.56 |
Financial Efficiency
Return on Equity is 12.9% and Return on Invested Capital is -27.95%.
| 12.9% |
| 8.88% |
| -27.95% |
| $53,937.5 |
| $668,875 |
| 80 |
| 0.01 |
| n/a |
Taxes
| -4.01M |
| -16.86% |
Stock Price Statistics
The stock price has increased by -36.73% in the last 52 weeks. The beta is 0.9, so PureTech Health's price volatility has been higher than the market average.
| 0.9 |
| -36.73% |
| 17.47 |
| 19.32 |
| 59.64 |
| 5,334 |
Income Statement
In the last 12 months, PureTech Health had revenue of 4.32M and earned 53.51M in profits. Earnings per share was 2.
| 4.32M |
| 4.32M |
| -136.09M |
| 53.51M |
| 37.38M |
| 33.81M |
| 2 |
Balance Sheet
The company has 280.64M in cash and 22.36M in debt, giving a net cash position of 258.28M.
| 280.64M |
| 22.36M |
| 258.28M |
| 32.49M |
| 602.63M |
| 344.87M |
Cash Flow
In the last 12 months, operating cash flow was -134.37M and capital expenditures -11K, giving a free cash flow of -134.38M.
| -134.37M |
| -11K |
| -134.38M |
| -0.5 |
Margins
Gross margin is 100%, with operating and profit margins of -3154% and 1240.09%.
| 100% |
| -3154% |
| 550.96% |
| 1240.09% |
| 866.33% |
| -3154% |
| -3114.25% |
Dividends & Yields
PRTC does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| 10.75% |
| -2.7% |
Analyst Forecast
The average price target for PRTC is $45, which is 137.7% higher than the current price. The consensus rating is "Buy".
| $45 |
| 137.7% |
| Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| $50 |
| 164.13% |
| 2.62 |
| -86.16% |
Scores
| 1.24 |
| 3 |